SEC Form D · filed March 25, 2021
Vigeo Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Peter B. Finn · Boston, MAExecJames E. Mahoney · Cambridge, MADirectorStephanie E. O'Brien · Cambridge, MADirectorWesterly E. Nolin, Ph.D · Cambridge, MADirectorJing Watnick · Cambridge, MAExec · DirectorRonald J. Masciantonio · Philadelphia, PADirectorLloyd T. Rochford · Rancho Mirage, CADirectorWilliam R. Broaddrick · Broken Arrow, OKDirectorMark Ronay · PORTLAND, ORExec · DirectorSteven W. Davis · Birmingham, ALExecMatthew Kennedy · New York, NYExecSudhakar Pennam · Irving, TXExec · DirectorTony Ross · SEATTLE, WADirectorJames H. Tobin · Marlton, NJDirectorJohn H. Bakewell · Marlton, NJDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗